We are live on ! Find out more
PSIL icon

AdvisorShares Psychedelics ETF

11 hedge funds and large institutions have $531K invested in AdvisorShares Psychedelics ETF in 2022 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.41% less ownership

Funds ownership: 1.05%0.64% (-0.41%)

8% less funds holding

Funds holding: 1211 (-1)

11% less capital invested

Capital invested by funds: $597K → $531K (-$66K)

33% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 3

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

Holders
11
Holders Change
-1
Holders Change %
-8.33%
% of All Funds
0.19%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
1
Reduced
2
Closed
3
Calls
Puts
Net Calls
Net Calls Change

PSIL Hedge Fund Activity: Q3 2022 in Review

11 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in AdvisorShares Psychedelics ETF (PSIL) for Q3 2022, worth a combined $531K — down 11% from $597K a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of PSIL and 2 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 1 added.

The largest buyer was Gofen & Glossberg, adding an estimated $15.9K. The largest seller was Morgan Stanley, cutting an estimated $59.7K.

  • 11 institutional investors held AdvisorShares Psychedelics ETF (PSIL) as of Q3 2022, down from 12 in Q2 2022.
  • Funds reported $531K of AdvisorShares Psychedelics ETF stock for Q3 2022, down 11% quarter-over-quarter.
  • 2 funds opened new AdvisorShares Psychedelics ETF positions in Q3 2022 and 3 closed out, a net change of -1 holder.
  • The largest AdvisorShares Psychedelics ETF buyer in Q3 2022 was Gofen & Glossberg, an estimated $15.9K added.
  • The largest AdvisorShares Psychedelics ETF seller in Q3 2022 was Morgan Stanley, an estimated $59.7K sold.

Based on aggregated 13F filings for Q3 2022.